Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
mood disorders precision medicine consortium[Corporate Author]
(7 results)?
The Metabolome-Wide Signature of Major Depressive Disorder.
Res Sq [Preprint]. 2023 Sep 21:rs.3.rs-3127544. doi: 10.21203/rs.3.rs-3127544/v1.
Res Sq. 2023.
PMID: 37790319
Free PMC article.
Preprint.
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder.
Bhattacharyya S, MahmoudianDehkordi S, Sniatynski MJ, Belenky M, Marur VR, Rush AJ, Craighead WE, Mayberg HS, Dunlop BW, Kristal BS, Kaddurah-Daouk R; Mood Disorder Precision Medicine Consortium.
Bhattacharyya S, et al.
medRxiv [Preprint]. 2024 Apr 3:2024.04.02.24304677. doi: 10.1101/2024.04.02.24304677.
medRxiv. 2024.
PMID: 38633777
Free PMC article.
Preprint.
Item in Clipboard
Cite
Cite